Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation

• Auteurs principaux: Xiaoye Li (Auteur), Xiaochun Zhang (Auteur), Qinchun Jin (Auteur), Ying Xue (Auteur), Wenjing Lu (Auteur), Junbo Ge (Auteur), Daxin Zhou (Auteur), Qianzhou Lv (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Objective: Due to the clinical complexity of warfarin, novel oral anticoagulation (NOAC) has been a feasible and safe alternative anticoagulant approach during left atrial appendage closure (LAAC). This study was designed to compare the efficacy and safety of rivaroxaban and dabigatran for nonvalvul...